We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
VERU

Price
0.54
Stock movement up
+0.02 (3.47%)
Company name
Veru Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
79.44M
Ent value
77.30M
Price/Sales
5.64
Price/Book
2.11
Div yield
51.59%
Div growth
-
Growth years
2
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
42.01%
1 year return
-56.23%
3 year return
-50.99%
5 year return
-29.15%
10 year return
-16.41%
Last updated: 2025-04-12

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share0.28
Dividend yield51.59%
Payout frequencyQuarterly
Maximum yield75.68%
Average yield17.35%
Minimum yield1.18%
Discount to avg yield66.37%
Upside potential197.32%
Yield as % of max yield68.18%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield51.59%
Current yield distribution4.76%
Yield at 100% (Min)1.18%
Yield at 90%2.32%
Yield at 80%3.15%
Yield at 50% (Median)8.85%
Yield at 20%33.17%
Yield at 10%42.50%
Yield at 0% (Max)75.68%

Dividend per share

Loading...
Dividend per share data
Years of growth2 years
CCC status-
Dividend per share0.28
Payout frequencyQuarterly
Ex-div date28 Apr 2014
EPS (TTM)-0.36
EPS (1y forward)-0.30
EPS growth (5y)42.01%
EPS growth (5y forward)-

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
VERUS&P500
DGR MR16.67%-13.74%
DGR TTM12.00%6.60%
DGR 3 years-5.24%
DGR 5 years-5.40%
DGR 10 years-7.07%
DGR 15 years-6.12%
Time since last change announced4402 days
EPS growth (5y)42.01%
EPS growth (5y forward)-

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM--
Average--
Forward-93.33%-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales5.64
Price to Book2.11
EV to Sales5.49

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count146.38M
EPS (TTM)-0.36
FCF per share (TTM)-0.19

Income statement

Loading...
Income statement data
Revenue (TTM)14.09M
Gross profit (TTM)4.71M
Operating income (TTM)-53.20M
Net income (TTM)-53.04M
EPS (TTM)-0.36
EPS (1y forward)-0.30

Margins

Loading...
Margins data
Gross margin (TTM)33.41%
Operating margin (TTM)-377.52%
Profit margin (TTM)-376.38%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash29.15M
Net receivables1.64M
Total current assets38.48M
Goodwill6.88M
Intangible assets0.00
Property, plant and equipment9.20M
Total assets64.63M
Accounts payable3.02M
Short/Current long term debt13.68M
Total current liabilities10.62M
Total liabilities27.01M
Shareholder's equity37.62M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-26.81M
Capital expenditures (TTM)308.16K
Free cash flow (TTM)-27.49M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-140.98%
Return on Assets-82.06%
Return on Invested Capital-109.99%
Cash Return on Invested Capital-57.00%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.51
Daily high0.55
Daily low0.51
Daily Volume765K
All-time high23.78
1y analyst estimate3.40
Beta-0.46
EPS (TTM)-0.36
Dividend per share0.28
Ex-div date28 Apr 2014
Next earnings date6 May 2025

Downside potential

Loading...
Downside potential data
VERUS&P500
Current price drop from All-time high-97.72%-12.89%
Highest price drop-98.44%-56.47%
Date of highest drop19 Jan 20249 Mar 2009
Avg drop from high-52.77%-11.07%
Avg time to new high82 days12 days
Max time to new high1920 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
VERU (Veru Inc) company logo
Marketcap
79.44M
Marketcap category
Small-cap
Description
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Employees
189
Investor relations
-
SEC filings
CEO
Mitchell Shuster Steiner
Country
USA
City
Miami
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...